GeneTex
United States (US)

Lipocalin-2 recombinant protein

Lipocalin-2-recombinant-protein-GTX65156-WB-1_18121411_365.jpg

Cat No. GTX65156

Application WB, ELISA, Functional Assay, Apuri, Blocking
Reactivity Human
Species Human
APPLICATION

Calculated MW

20 kDa. ( Note )
PROPERTIES

Form

Lyophilized powder

Storage

Reconstitute in water to a concentration 0.1-1 mg/ml. The solution can then be further diluted to other aqueous solutions.
Aliquot and store at -20ºC.

Antigen Species

Human

Expression System

E. coli

Purification


Purity was assessed by SDS-PAGE (≥95%) and by HPLC (≥95%).

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

Lipocalin2, LCN2., LCN2, Oncogene 24p3, 25 kDa alpha2microglobulinrelated subunit of MMP9, 25 kDa alpha2microglobulinrelated subunit of MM, p25, Neutrophil gelatinaseassociated lipocalin, Neutrophil gelatinase-associated lipocalin, 25 kDa alpha-2-microglobulin-related subunit of MM, Oncogene24p3, Lipocalin-2, Lipocalin 2

Background

Lipocalin-2 (LCN-2), a secreted glycoprotein, is an adipokine that potentially connects obesity and its related adipose inflammation. Lipocalin-2 has also been implicated in a variety of processes including cell differentiation, tumorigenesis, and apoptosis. The recombinant human Lipocalin-2 consisting of 178 amino acids (a.a. 21-198, Accession# NP_00555) was expressed from E. coli and purified using proprietary technology.

Research Area

DATA IMAGES
Lipocalin-2-recombinant-protein-GTX65156-WB-1_18121411_365.jpg

GTX65156 WB Image

Purity of recombinant human Lipocalin-2 (2 µg) was analyzed by reduced SDS-PAGE electrophoresis.